Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05678647
NA
Sucrosomial Iron and Iron Sulphate to Blood Donors
Sponsor: Uppsala University Hospital
View on ClinicalTrials.gov
Summary
2 different oral iron supplementations after blood donation are compared.
Official title: Randomized Open Comparative Trial of Oral Sucrosomial Iron (SiderAl Forte®) and Oral Iron Sulphate (Duroferon®) to Blood Donors.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2023-01-31
Completion Date
2026-01-01
Last Updated
2025-04-23
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Sucrosomial Iron
20 capsules of Sucrosomial Iron 30 mg is given after blood donation
DRUG
Iron Sulfate
20 tablets of oral iron sulphate (Duroferon®) 100 mg is given after blood donation
Locations (1)
Clinical Immunology and Transfusion Medicine, Uppsala University Hospital
Uppsala, Sweden